View Item 

Show simple item record

Antimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics
dc.contributor.authorRaglow, Zoe
dc.contributor.authorAdvani, Sonali D.
dc.contributor.authorAitken, Samuel L.
dc.contributor.authorPatel, Payal K.
dc.date.accessioned2022-11-09T21:19:14Z
dc.date.available2023-11-09 16:19:12en
dc.date.available2022-11-09T21:19:14Z
dc.date.issued2022-10
dc.identifier.citationRaglow, Zoe; Advani, Sonali D.; Aitken, Samuel L.; Patel, Payal K. (2022). "Antimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics." Transplant Infectious Disease 24(5): n/a-n/a.
dc.identifier.issn1398-2273
dc.identifier.issn1399-3062
dc.identifier.urihttps://hdl.handle.net/2027.42/175110
dc.description.abstractBackgroundSolid organ transplant (SOT) recipients are challenging populations for antimicrobial stewardship interventions due to a variety of reasons, including immunosuppression, consequent risk of opportunistic and donor-derived infections, high rates of infection with multi-drug resistant organisms (MDROs), Clostridioides difficile, and need for prolonged antimicrobial prophylaxis. Despite this, data on stewardship interventions and metrics that address the distinct needs of these patients are limited.MethodsWe performed a narrative review of the current state of antimicrobial stewardship in SOT recipients, existing interventions and metrics in this population, and considerations for implementation of transplant-specific stewardship programs.ResultsAntimicrobial stewardship metrics are evolving even in the general patient population. Data on metrics applicable to the SOT population are even more limited. Standard process, outcomes, and balancing metrics may not always apply to the SOT population. A successful stewardship program for SOT recipients requires reviewing existing data, applying general stewardship principles, and understanding the nuances of SOT patients.ConclusionAs antimicrobial stewardship interventions are being implemented in SOT recipients; new metrics are needed to assess their impact. In conclusion, SOT patients present a challenging but important opportunity for antimicrobial stewards.AbbreviationsSOT, antimicrobial stewardship program, MDRO, Clostridioides difficile infection, Centers for Disease Control and Prevention, Infectious Diseases Society of America, prospective audit and feedback, hematopoietic cell transplant, cytomegalovirus, trimethoprim-sulfamethoxazole, surgical site infections, nucleic acid amplification testing, days of therapy, defined daily dose, and length of stay.
dc.publisherWorld health Organization
dc.publisherWiley Periodicals, Inc.
dc.subject.otherantimicrobial stewardship
dc.subject.otherinterventions
dc.subject.othermetrics
dc.subject.othersolid organ transplant
dc.titleAntimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175110/1/tid13883_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175110/2/tid13883.pdf
dc.identifier.doi10.1111/tid.13883
dc.identifier.sourceTransplant Infectious Disease
dc.identifier.citedreferenceAkpan MR, Ahmad R, Shebl NA, Ashiru-Oredope D, A review of quality measures for assessing the impact of antimicrobial stewardship programs in hospitals. Antibiotics. 2016; 5 ( 1 ) https://doi.org/10.3390/antibiotics5010005
dc.identifier.citedreferenceSo M, Yang DY, Bell C, Humar A, Morris A, Husain S. Solid organ transplant patients: are there opportunities for antimicrobial stewardship? Clin Transplant. 2016; 30 ( 6 ): 659 - 668. https://doi.org/10.1111/ctr.12733
dc.identifier.citedreferenceLópez-Medrano F, Juan RS, Lizasoain M, et al. A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital. Clin Microbiol Infect. 2013; 19 ( 1 ): 56 - 61. https://doi.org/10.1111/j.1469-0691.2012.03891.x
dc.identifier.citedreferenceMorris AM, Antimicrobial stewardship programs: Appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis. 2014; 6 ( 2 ): 101 - 112. https://doi.org/10.1007/s40506-014-0015-3
dc.identifier.citedreferenceBrotherton AL. Metrics of antimicrobial stewardship programs. Med Clin North Am. 2018; 102 ( 5 ): 965 - 976. https://doi.org/10.1016/j.mcna.2018.05.008
dc.identifier.citedreferenceBennett N, Schulz L, Boyd S, Newland JG, Understanding inpatient antimicrobial stewardship metrics. Am J Health Syst Pharm. 2018; 75 ( 4 ): 230 - 238. https://doi.org/10.2146/ajhp160335
dc.identifier.citedreferenceBrett KE, Ritchie LJ, Ertel E, Bennett A, Knoll GA. Quality metrics in solid organ transplantation: a systematic review. Transplantation. 2018; 102 ( 7 ): e308 - e330. https://doi.org/10.1097/TP.0000000000002149
dc.identifier.citedreferenceHosseini-Moghaddam SM, Luo B, Bota SE, et al. Incidence and outcomes associated with clostridioides difficile infection in solid organ transplant recipients. JAMA Netw Open. 2021; 4 ( 12 ): e2141089. https://doi.org/10.1001/jamanetworkopen.2021.41089
dc.identifier.citedreferenceAvni T, Babitch T, Ben-Zvi H, et al. Clostridioides difficile infection in immunocompromised hospitalized patients is associated with a high recurrence rate. Int J Infect Dis. 2020; 90: 237 - 242. https://doi.org/10.1016/j.ijid.2019.10.028
dc.identifier.citedreferenceWang N, Athans V, Neuner E, Bollinger J, Spinner M, Brizendine K. A pharmacist-driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients. Transpl Infect Dis. 2018; 20 ( 6 ): e12991. https://doi.org/10.1111/tid.12991
dc.identifier.citedreferenceEvans SR, Rubin D, Follmann D, et al. Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR). Clin Infect Dis. 2015; 61 ( 5 ): 800 - 806. https://doi.org/10.1093/cid/civ495
dc.identifier.citedreferenceBerry PS, Rosenberger LH, Guidry CA, Agarwal A, Pelletier S, Sawyer RG. Intraoperative versus extended antibiotic prophylaxis in liver transplant surgery: a randomized controlled pilot trial. Liver Transpl. 2019; 25 ( 7 ): 1043 - 1053. https://doi.org/10.1002/lt.25486
dc.identifier.citedreferenceMoehring RW, Anderson DJ, Cochran RL, et al. Expert consensus on metrics to assess the impact of Patient-level antimicrobial stewardship interventions in Acute-care settings. Clin Infect Dis. 2017; 64 ( 3 ): 377 - 383. https://doi.org/10.1093/cid/ciw787
dc.identifier.citedreferenceGums JG, Yancey RW, Hamilton CA, Kubilis PS, A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999; 19 ( 12 ): 1369 - 1377. https://doi.org/10.1592/phco.19.18.1369.30898
dc.identifier.citedreferenceCarling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003; 24 ( 9 ): 699 - 706. https://doi.org/10.1086/502278
dc.identifier.citedreferencePérez JL, Ayats J, de Oña M, Pumarola T. The role of the clinical microbiology laboratory in solid organ transplantation programs. Enferm Infecc Microbiol Clin. 2012; 30 (Suppl 2 ): 2 - 9. https://doi.org/10.1016/S0213-005X(12)70076-9
dc.identifier.citedreferenceMacVane SH, Hurst JM, Steed LL, The role of antimicrobial stewardship in the clinical microbiology laboratory: Stepping up to the plate. Open Forum Infect Dis. 2016; 3 ( 4 ): ofw201. https://doi.org/10.1093/ofid/ofw201
dc.identifier.citedreferenceSo M, Hand J, Forrest G, et al. White paper on antimicrobial stewardship in solid organ transplant recipients. Am J Transplant. 2022; 22 ( 1 ): 96 - 112. https://doi.org/10.1111/ajt.16743
dc.identifier.citedreferenceSime FB, Roberts MS, Roberts JA. Optimization of dosing regimens and dosing in special populations. Clin Microbiol Infect. 2015; 21 ( 10 ): 886 - 893. https://doi.org/10.1016/j.cmi.2015.05.002
dc.identifier.citedreferenceKjærsgaard M, Leth RA, Udupi A, Ank N. Antibiotic stewardship based on education: minor impact on knowledge, perception and attitude. Infect Dis. 2019; 51 ( 10 ): 753 - 763. https://doi.org/10.1080/23744235.2019.1648856
dc.identifier.citedreferenceFirouzabadi D, Mahmoudi L. Knowledge, attitude, and practice of health care workers towards antibiotic resistance and antimicrobial stewardship programmes: a cross-sectional study. J Eval Clin Pract. 2020; 26 ( 1 ): 190 - 196. https://doi.org/10.1111/jep.13177
dc.identifier.citedreferenceWHO. Global Action Plan on Antimicrobial Resistance. World health Organization; 2015.
dc.identifier.citedreferenceCox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017; 23 ( 11 ): 812 - 818. https://doi.org/10.1016/j.cmi.2017.07.010
dc.identifier.citedreferencePatel PK. Minding the gap: rethinking implementation of antimicrobial stewardship in India. Infect Control Hosp Epidemiol. 2019; 40 ( 5 ): 520 - 521. https://doi.org/10.1017/ice.2019.62
dc.identifier.citedreferenceRamesh V, Pal C. Organ donation and transplantation in India in 2019. Exp Clin Transplant. 2021; 19 ( 12 ): 1313 - 1321. https://doi.org/10.6002/ect.2021.0105
dc.identifier.citedreferenceHamdy RF, Zaoutis TE, Seo SK, Antifungal stewardship considerations for adults and pediatrics. Virulence. 2017; 8 ( 6 ): 658 - 672. https://doi.org/10.1080/21505594.2016.1226721
dc.identifier.citedreferenceSchuts EC, Hulscher MEJL, Mouton JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016; 16 ( 7 ): 847 - 856. https://doi.org/10.1016/S1473-3099(16)00065-7
dc.identifier.citedreferenceDavey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017; 2: CD003543. https://doi.org/10.1002/14651858.CD003543.pub4
dc.identifier.citedreferenceBaur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017; 17 ( 9 ): 990 - 1001. https://doi.org/10.1016/S1473-3099(17)30325-0
dc.identifier.citedreferenceNathwani D, Varghese D, Stephens J, Ansari W, Martin S, Charbonneau C. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019; 8: 35. https://doi.org/10.1186/s13756-019-0471-0
dc.identifier.citedreferenceAbbo LM, Ariza-Heredia EJ. Antimicrobial stewardship in immunocompromised hosts. Infect Dis Clin North Am. 2014; 28 ( 2 ): 263 - 279. https://doi.org/10.1016/j.idc.2014.01.008
dc.identifier.citedreferencede Gouvêa EF, Martins IS, Halpern M, et al. The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection. BMC Infect Dis. 2012; 12: 351. https://doi.org/10.1186/1471-2334-12-351
dc.identifier.citedreferenceSimkins J, Morris MI, Camargo JF, Vianna R, Beduschi T, Abbo LM. Clinical outcomes of intestinal transplant recipients colonized with multidrug-resistant organisms: a retrospective study. Transpl Int. 2017; 30 ( 9 ): 924 - 931. https://doi.org/10.1111/tri.12987
dc.identifier.citedreferencePereira MR, Scully BF, Pouch SM, et al. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl. 2015; 21 ( 12 ): 1511 - 1519. https://doi.org/10.1002/lt.24207
dc.identifier.citedreferenceDubberke ER, Burdette SD, AIDCo Practice. Clostridium difficile infections in solid organ transplantation. Am J Transpl. 2013; 13 (Suppl 4 ): 42 - 49. https://doi.org/10.1111/ajt.12097
dc.identifier.citedreferenceLuo R, Weinberg JM, Barlam TF. The impact of clostridium difficile infection on future outcomes of solid organ transplant recipients. Infect Control Hosp Epidemiol. 05 2018; 39 ( 5 ): 563 - 570. https://doi.org/10.1017/ice.2018.48
dc.identifier.citedreferencePollack LA, Srinivasan A. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014; 59 (Suppl 3 ): S97 - S100. https://doi.org/10.1093/cid/ciu542
dc.identifier.citedreferenceDoernberg SB, Abbo LM, Burdette SD, et al. Essential resources and strategies for antibiotic stewardship programs in the acute care setting. Clin Infect Dis. 2018; 67 ( 8 ): 1168 - 1174. https://doi.org/10.1093/cid/ciy255
dc.identifier.citedreferenceSeo SK, Lo K, Abbo LM. Current state of antimicrobial stewardship at solid organ and hematopoietic cell transplant centers in the United States. Infect Control Hosp Epidemiol. 2016; 37 ( 10 ): 1195 - 1200. https://doi.org/10.1017/ice.2016.149
dc.identifier.citedreferenceAccreditation JCoH. Approved: new antimicrobial stewardship standard. Jt Comm Perspect. 2016; 36 ( 7 ): 3 - 4.
dc.identifier.citedreferenceTamma PD, Avdic E, Keenan JF, et al. What is the more effective antibiotic stewardship intervention: preprescription authorization or postprescription review with feedback? Clin Infect Dis. 2017; 64 ( 5 ): 537 - 543. https://doi.org/10.1093/cid/ciw780
dc.identifier.citedreferenceSo M, Morris AM, Nelson S, Bell CM, Husain S. Antimicrobial stewardship by academic detailing improves antimicrobial prescribing in solid organ transplant patients. Eur J Clin Microbiol Infect Dis. Oct 2019; 38 ( 10 ): 1915 - 1923. https://doi.org/10.1007/s10096-019-03626-8
dc.identifier.citedreferenceYeo CL, Chan DS, Earnest A, et al. Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore. Eur J Clin Microbiol Infect Dis. 2012; 31 ( 4 ): 583 - 590. https://doi.org/10.1007/s10096-011-1351-6
dc.identifier.citedreferenceKorayem GB, Zangeneh TT, Matthias KR. Recurrence of urinary tract infections and development of urinary-specific antibiogram for kidney transplant recipients. J Glob Antimicrob Resist. 2018; 12: 119 - 123. https://doi.org/10.1016/j.jgar.2017.08.009
dc.identifier.citedreferenceHalim I, Goel N, Gupta A, Wattal C. Prevalence and antibiogram of urinary tract infections in renal transplant recipients at a tertiary care hospital in North India. J Assoc Physicians India. 2020; 68 ( 5 ): 30 - 31.
dc.identifier.citedreferenceRosa R, Simkins J, Camargo JF, Martinez O, Abbo LM. Solid organ transplant antibiograms: an opportunity for antimicrobial stewardship. Diagn Microbiol Infect Dis. 2016; 86 ( 4 ): 460 - 463. https://doi.org/10.1016/j.diagmicrobio.2016.08.018
dc.identifier.citedreferenceBarlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis 2016; 62 ( 10 ): e51 - 77. https://doi.org/10.1093/cid/ciw118
dc.identifier.citedreferenceTamma PD, Conley AT, Cosgrove SE, et al. Association of 30-day mortality with oral step-down vs continued intravenous therapy in patients hospitalized with enterobacteriaceae bacteremia. JAMA Intern Med. 2019; 179 ( 3 ): 316 - 323. https://doi.org/10.1001/jamainternmed.2018.6226
dc.identifier.citedreferenceAsberg A, Humar A, Rollag H, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2007; 7 ( 9 ): 2106 - 2113. https://doi.org/10.1111/j.1600-6143.2007.01910.x
dc.identifier.citedreferenceJohnson MD, Lewis RE, Dodds Ashley ES, et al. Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium. J Infect Dis. 2020; 222 (Suppl 3 ): S175 - S198. https://doi.org/10.1093/infdis/jiaa394
dc.identifier.citedreferenceKotton CN, Kumar D, Caliendo AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018; 102 ( 6 ): 900 - 931. https://doi.org/10.1097/TP.0000000000002191
dc.identifier.citedreferenceRazonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33 ( 9 ): e13512. https://doi.org/10.1111/ctr.13512
dc.identifier.citedreferenceMacFadden DR, LaDelfa A, Leen J, et al. Impact of reported Beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study. Clin Infect Dis. 2016; 63 ( 7 ): 904 - 910. https://doi.org/10.1093/cid/ciw462
dc.identifier.citedreferenceTrubiano JA, Thursky KA, Stewardson AJ, et al. Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation. Clin Infect Dis. 2017; 65 ( 1 ): 166 - 174. https://doi.org/10.1093/cid/cix244
dc.identifier.citedreferenceDevchand M, Kirkpatrick CMJ, Stevenson W, et al. Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention. J Antimicrob Chemother. 2019; 74 ( 6 ): 1725 - 1730. https://doi.org/10.1093/jac/dkz082
dc.identifier.citedreferenceImlay H, Krantz EM, Stohs EJ, et al. Reported β-lactam and other antibiotic allergies in solid organ and hematopoietic cell transplant recipients. Clin Infect Dis. 2020; 71 ( 7 ): 1587 - 1594. https://doi.org/10.1093/cid/ciz1025
dc.identifier.citedreferenceKhumra S, Chan J, Urbancic K, et al. Antibiotic allergy labels in a liver transplant recipient study. Antimicrob Agents Chemother. 2017; 61 ( 5 ):e00078-17. https://doi.org/10.1128/AAC.00078-17
dc.identifier.citedreferenceModi AR, Majhail NS, Rybicki L, et al. Penicillin allergy skin testing as an antibiotic stewardship intervention reduces alternative antibiotic exposures in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2019; 21 ( 6 ): e13175. https://doi.org/10.1111/tid.13175
dc.identifier.citedreferenceTaremi M, Artau A, Foolad F, et al. Safety, efficacy, and clinical impact of penicillin skin testing in immunocompromised cancer patients. J Allergy Clin Immunol Pract. 2019; 7 ( 7 ): 2185 - 2191.e1. https://doi.org/10.1016/j.jaip.2019.03.025
dc.identifier.citedreferenceFoolad F, Berlin S, White C, Dishner E, Jiang Y, Taremi M, The impact of penicillin skin testing on aztreonam stewardship and cost savings in immunocompromised cancer patients. Open Forum Infect Dis. 2019; 6 ( 10 ): ofz371. https://doi.org/10.1093/ofid/ofz371
dc.identifier.citedreferencePryor JB, Olyaei AJ, Kirsch D, Strasfeld L. Sulfonamide desensitization in solid organ transplant recipients: a protocol-driven approach during the index transplant hospitalization. Transpl Infect Dis. 2019; 21 ( 6 ): e13191. https://doi.org/10.1111/tid.13191
dc.identifier.citedreferenceKumar D, Mian M, Singer L, Humar A. An interventional study using Cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation. Am J Transplant. 2017; 17 ( 9 ): 2468 - 2473. https://doi.org/10.1111/ajt.14347
dc.identifier.citedreferenceJorgenson MR, Descourouez JL, Schulz LT, et al. The development and implementation of stewardship initiatives to optimize the prevention and treatment of cytomegalovirus infection in solid-organ transplant recipients. Infect Control Hosp Epidemiol. 2020; 41 ( 9 ): 1068 - 1074. https://doi.org/10.1017/ice.2020.203
dc.identifier.citedreferenceHusain S, Bhaskaran A, Rotstein C, et al. A strategy for prevention of fungal infections in lung transplantation: role of bronchoalveolar lavage fluid galactomannan and fungal culture. J Heart Lung Transplant. 2018; 37 ( 7 ): 886 - 894. https://doi.org/10.1016/j.healun.2018.02.006
dc.identifier.citedreferenceSeidelman J, Anderson DJ. Surgical site infections. Infect Dis Clin North Am. 2021; 35 ( 4 ): 901 - 929. https://doi.org/10.1016/j.idc.2021.07.006
dc.identifier.citedreferenceCengiz TB, Jarrar A, Power C, Joyce D, Anzlovar N, Morris-Stiff G, Antimicrobial stewardship reduces surgical site infection rate, as well as number and severity of pancreatic fistulae after pancreatoduodenectomy. Surg Infect. 2020; 21 ( 3 ): 212 - 217. https://doi.org/10.1089/sur.2019.108
dc.identifier.citedreferenceFrenette C, Sperlea D, Leharova Y, Thirion DJ. Impact of an infection control and antimicrobial stewardship program on solid organ transplantation and hepatobiliary surgical site infections. Infect Control Hosp Epidemiol. 2016; 37 ( 12 ): 1468 - 1474. https://doi.org/10.1017/ice.2016.213
dc.identifier.citedreferenceAbbo LM, Grossi PA, AICo Practice. Surgical site infections: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33 ( 9 ): e13589. https://doi.org/10.1111/ctr.13589
dc.identifier.citedreferenceNaumnik B, Małyszko J, Chyczewski L, Kovalchuk O, Myśliwiec M, Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients. Transplant Proc. 2007; 39 ( 9 ): 2748 - 2750. https://doi.org/10.1016/j.transproceed.2007.08.040
dc.identifier.citedreferenceGajurel K, Dhakal R, Deresinski S. Diagnosis and treatment of histoplasmosis in solid organ transplant patients. Curr Opin Infect Dis. 2018; 31 ( 4 ): 301 - 308. https://doi.org/10.1097/QCO.0000000000000457
dc.identifier.citedreferenceYoung BA, Hanson KE, Gomez CA, Molecular diagnostic advances in transplant infectious diseases. Curr Infect Dis Rep. 2019; 21 ( 12 ): 52. https://doi.org/10.1007/s11908-019-0704-7
dc.identifier.citedreferenceTimbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and Meta-analysis. Clin Infect Dis. 2017; 64 ( 1 ): 15 - 23. https://doi.org/10.1093/cid/ciw649
dc.identifier.citedreferenceMahle RE, Suchindran S, Henao R, et al. Validation of a host gene expression test for Bacterial/Viral discrimination in immunocompromised hosts. Clin Infect Dis. 2021; 73 ( 4 ): 605 - 613. https://doi.org/10.1093/cid/ciab043
dc.identifier.citedreferenceMcCort MN, Oehler C, Enriquez M, et al. Universal molecular Clostridioides difficile screening and overtreatment in solid organ transplant recipients. Transpl Infect Dis. 2020; 22 ( 5 ): e13375. https://doi.org/10.1111/tid.13375
dc.identifier.citedreferenceBrotherton AL. Metrics of antimicrobial stewardship programs. Med Clin North Am. 2018;102(5): 965 - 976.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
tid13883_am.pdf
Size:
977.6KB
Format:
PDF
View/Open
Name:
tid13883.pdf
Size:
567.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.